 |
 |
Read
more than 4,000 books online FREE! More than 1900 PDFs now available
for sale |
|
|
|
 |
|
Neuroscience Biomarkers and Biosignatures:
Converging Technologies, Emerging Partnerships: Workshop Summary
|
|
Status: Available Now
Size: 128 pages, 6 x 9
Publication Year:2008
|
|
|
| Print |
List Price |
Your Price |
|
 |
PAPERBACK
ISBN-10: 0-309-10889-6
ISBN-13: 978-0-309-10889-8
|
$32.50 |
$29.25 |
Add to Cart |
| PDF |
|
|
|
|
|
Authors:
Miriam Davis, Sarah Hanson, Bruce Altevogt, Rapporteurs, Forum on Neuroscience and Nervous System Disorders, Institute of Medicine Authoring Organizations
Description: Biomarkers, or biological markers, are quantitative measurements that offer researchers and clinicians valuable insight into diagnosis, treatment and prognosis for many disorders and diseases. A major goal in neuroscience medical research is establishing biomarkers for disorders of the nervous system. ... Read More
|
|
|
Full Text
Jump to this book's table of contents to begin reading online for free.
|
Web Search Builder
Use this book's key terms to search within this book, across our
collection, or across the Web.
Reference
Finder
Paste in your own text to find books that relate to your topic.
|
|
Description
Biomarkers, or biological markers, are quantitative measurements that offer researchers and clinicians valuable insight into diagnosis, treatment and prognosis for many disorders and diseases. A major goal in neuroscience medical research is establishing biomarkers for disorders of the nervous system. Given the promising potential and necessity for neuroscience biomarkers, the Institute of Medicine Forum on Neuroscience and Nervous System Disorders convened a public workshop and released the workshop summary entitled Neuroscience Biomarkers and Biosignatures: Converging Technologies, Emerging Partnerships. The workshop brought together experts from multiple areas to discuss the most promising and practical arenas in neuroscience in which biomarkers will have the greatest impact. The main objective of the workshop was to identify and discuss biomarker targets that are not currently being aggressively pursued but that could have the greatest near-term impact on the rate at which new treatments are brought forward for psychiatric and neurological disorders.
|
SIGN UP FOR...
New Title Emails
Read about the newest releases and receive special offers.
|
|
|